After Advanced Treatment, Sidra Medicine CMO to QNA: Advancing Revolutionary Therapies for Rare Diseases
Doha: Chief Medical Officer of Sidra Medicine, Prof. Ibrahim Janahi, said offering advanced gene-editing therapy for sickle cell disease and thalassemia reflects Sidra Medicine’s global standing in science and research.
According to Qatar News Agenc…